Massachusetts Financial Services CO Allovir, Inc. Transaction History

Massachusetts Financial Services CO

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 08, 2023	SELL	$2.15 - $3.64 $387,548 - $656,128	-180,255 Reduced 17.83%	830,873 $1.79 Million
Q2 2023 Aug 09, 2023	SELL	$3.17 - $5.82 $40,192 - $73,791	-12,679 Reduced 1.24%	1,011,128 $3.44 Million
Q1 2023 May 10, 2023	BUY	$3.94 - $7.05 $170,018 - $304,221	43,152 Added 4.4%	1,023,807 $4.03 Million
Q4 2022 Feb 13, 2023	BUY	$4.7 - $9.98 $680,917 - $1.45 Million	144,876 Added 17.33%	980,655 $5.03 Million
Q3 2022 Nov 09, 2022	BUY	$4.13 - $8.79 $233,803 - $497,610	56,611 Added 7.27%	835,779 $6.59 Million
Q2 2022 Aug 09, 2022	SELL	$3.26 - $7.06 $19,077 - $41,315	-5,852 Reduced 0.75%	779,168 $3.04 Million
Q1 2022 May 11, 2022	BUY	$6.75 - $13.52 $146,414 - $293,262	21,691 Added 2.84%	785,020 $5.3 Million
Q4 2021 Feb 10, 2022	SELL	$12.94 - $25.99 $72,709 - $146,037	-5,619 Reduced 0.73%	763,329 $9.88 Million
Q3 2021 Nov 10, 2021	BUY	$16.97 - $25.06 $2.67 Million - $3.94 Million	157,396 Added 25.74%	768,948 $19.3 Million
Q2 2021 Aug 13, 2021	SELL	$19.44 - $25.06 $35,050 - $45,183	-1,803 Reduced 0.29%	611,552 $12.1 Million
Q1 2021 May 13, 2021	SELL	$20.81 - $45.5 $299,664 - $655,200	-14,400 Reduced 2.29%	613,355 $14.4 Million
Q4 2020 Feb 12, 2021	BUY	$23.94 - $46.81 $279,284 - $546,085	11,666 Added 1.89%	627,755 $24.1 Million
Q3 2020 Nov 12, 2020	BUY	$21.05 - $42.7 $13 Million - $26.3 Million	616,089 New	616,089 $16.9 Million

44.6M

14.9K

200

Ticker ALVR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 93,063,400
Market Cap $51.2M
Description
Allovir, Inc., a clinical-stage cell therapy company, engages in the research and development of allogeneic, off-the-shelf multi-virus specific T cell (VST) therapies to prevent and treat devastating viral-associated diseases. The company's lead product is posoleucel, an allogeneic, off-the-shelf VST therapy, to treat BK virus, cytomegalovirus, ...

Get notified when there are updates to the investment portfolio of Massachusetts Financial Services CO , based on Form 13F filings with the SEC.

Stay updated on Massachusetts Financial Services CO with notifications on news.